AstraZeneca Cashes In Moderna Chips
Sold 7.7% Stake In US COVID-19 Trailblazer
The firms' messenger RNA alliance inked back on 2013 is still very much ongoing but AstraZeneca decided to sell its considerable stake in the high-profile biotech to help finance its own pipeline.
